GBLX
Price:
$0.0002
Market Cap:
$81.41K
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.[Read more]
Industry
Biotechnology
IPO Date
2008-05-12
Stock Exchange
PNK
Ticker
GBLX
According to GB Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 27.88%. This represents a change of 302.04% compared to the average of 6.94% of the last 4 quarters.
The mean historical ROE of GB Sciences, Inc. over the last ten years is 5.97%. The current 27.88% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), GBLX's ROE was at its highest in in the March 2020 quarter at 9.75%. The ROE was at its lowest in in the March 2015 quarter at -801.49%.
Average
5.97%
Median
-33.66%
Minimum
-1552.94%
Maximum
59.71%
Discovering the peaks and valleys of GB Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 58.13%
Maximum Annual ROE = 59.71%
Minimum Annual Increase = -64240047.19%
Minimum Annual ROE = -1552.94%
Year | ROE | Change |
---|---|---|
2024 | 25.62% | -100.00% |
2023 | 59.71% | -64240047.19% |
2022 | -92.95% | -128.64% |
2021 | 324.50% | -97.53% |
2020 | 13.15% | -4713.93% |
2019 | -284.97% | 58.13% |
2018 | -180.21% | 51.43% |
2017 | -119.00% | -133.32% |
2016 | 357.11% | -123.00% |
2015 | -1552.94% | -2499.10% |
The current ROE of GB Sciences, Inc. (GBLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.90%
5-year avg
11.94%
10-year avg
5.97%
GB Sciences, Inc.’s ROE is greater than Biostage, Inc. (-526.75%), greater than Antibe Therapeutics Inc. (-49.77%), less than Awakn Life Sciences Corp. (175.85%), less than Tryp Therapeutics Inc. (131.45%), less than America Great Health (18.81%), greater than Theralink Technologies, Inc. (-41.95%), less than Adhera Therapeutics, Inc. (0%), less than SciSparc Ltd. (13.30%), greater than Cellectis S.A. (-87.48%), greater than Biotron Limited (-81.02%), greater than Regenicin, Inc. (-504.53%), less than AXIM Biotechnologies, Inc. (19.74%), less than Bioasis Technologies Inc. (54.15%), greater than MultiCell Technologies, Inc. (0%), less than Health Sciences Group, Inc. (164.07%), less than Wesana Health Holdings Inc. (0%), less than BetterLife Pharma Inc. (242.19%), less than Covalon Technologies Ltd. (0%), less than null (46.88%), greater than null (-4.23%),
Company | ROE | Market cap |
---|---|---|
-526.75% | $57.82M | |
-49.77% | $11.45M | |
175.85% | $3.33M | |
131.45% | $5.42M | |
18.81% | $10.59M | |
-41.95% | $615.15K | |
0% | $1.44K | |
13.30% | $2.31M | |
-87.48% | $183.12M | |
-81.02% | $13.08M | |
-504.53% | $15.35K | |
19.74% | $1.45M | |
54.15% | $28.44M | |
0% | $50.01K | |
164.07% | $187.09K | |
0% | $171.26K | |
242.19% | $10.22M | |
0% | $67.67M | |
46.88% | $0 | |
-4.23% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GB Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GB Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GB Sciences, Inc.'s ROE?
How is the ROE calculated for GB Sciences, Inc. (GBLX)?
What is the highest ROE for GB Sciences, Inc. (GBLX)?
What is the 3-year average ROE for GB Sciences, Inc. (GBLX)?
What is the 5-year average ROE for GB Sciences, Inc. (GBLX)?
How does the current ROE for GB Sciences, Inc. (GBLX) compare to its historical average?